Podcasts
Neurology Consultant
John Markman, MD, on Subcutaneous Tanezumab vs Tramadol or Placebo for Chronic Low Back Pain
In this podcast, Dr. Markman discusses promising findings from a large phase 3 trial comparing subcutaneous tanezumab, a monoclonal antibody with a novel mechanism of action, vs tramadol and placebo among patients with chronic low back pain and history of inadequate response or intolerance to standard-of-care analgesics. Read the transcript here. This study was featured in the 2020 American Academy of Neurology Science Highlights.
Neurosurgery Consultant Article
Date: 6/24/2020
NPR
Words Matter When Talking About Pain With Your Doctor
If you go to the doctor with a painful problem, you will likely be asked to rate that pain on a scale of zero to 10, with zero meaning no pain at all and 10, the worst pain imaginable. But many doctors and nurses say rating by numbers isn't working, and patients may not be getting the proper treatment for their pain. NPR's Patti Neighmond reports.
Date: 7/23/2018